Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

£150 million boost for Welsh SMEs

This article was originally published in Scrip

Executive Summary

A £150 million fund to develop small- and medium-sized companies in Wales is due to be released this month, Finance Wales investment director Peter Wright told attendees at BioWales 2009.

You may also be interested in...



UK Devices Bill Back On The Agenda As Govt Tries To Get COVID-19 Crisis Under Control

Post-Brexit planning is now fully back on the agenda in the UK, and work to shape its post-EU medtech regulatory future is also restarting.

A Message For Medtechs: Adapt For the Future While You Can

With the World Health Organization pressing for an inquiry into the coronavirus pandemic, it is clear that lessons must be learned for how future global public health emergencies must be handled. Medical technology has played a key role in halting the speed of the pandemic, but why has it taken an episode like COVID-19 for medtech’s true value to be recognized? ZS principal Brian Chapman says things must never go back to where they were.

UK’s COVID-19 Track-And-Trace Confusion Persists

Surveillance and track-and-trace have emerged as the new focus of the UK’s COVID-19 control strategy, but a workable plan is yet to crystalize.

Topics

UsernamePublicRestriction

Register

LL1132466

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel